IOMICS

Curated by Signal

AI-powered platform for drug design and development

Overview

AI-powered platform for drug design and development. The company's Cures Accelerator utilizes data points of scientific and clinical data along with automated machine learning, bioinformatics, computational chemistry for intelligent drug discovery, drug repurposing and polypharmacology.

Key facts

Founded: 2013
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Business model

7 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

MaxisIT
Clinical Data Management software
Health TechnologyMetuchen, United States
Dickson
Provider of environmental monitoring solutions for healthcare providers
Health TechnologyAddison, United States
Imaginostics
Provider of solution for magnetic resonance imaging biomarkers for diagnosis of neurological disorder
Health TechnologyCambridge, United States

About IOMICS

What does IOMICS do?

AI-powered platform for drug design and development.

Where is IOMICS headquartered?

IOMICS is headquartered in Cambridge, United States.

When was IOMICS founded?

IOMICS was founded in 2013.

Which sector is IOMICS in?

IOMICS operates in Health Technology.

Who are IOMICS's competitors?

Companies similar to IOMICS include MaxisIT, Dickson, and Imaginostics.